UCB BioSciences GmbH
🇩🇪Germany
Clinical Trials
21
Active:0
Completed:20
Trial Phases
4 Phases
Phase 1:4
Phase 2:1
Phase 3:10
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (20 trials with phase data)• Click on a phase to view related trials
Phase 3
10 (50.0%)Phase 4
5 (25.0%)Phase 1
4 (20.0%)Phase 2
1 (5.0%)Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
Phase 3
Completed
- Conditions
- Axial SpondyloarthritisNonradiographic Axial SpondyloarthritisNr-axSpA
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 317
- Registration Number
- NCT02552212
- Locations
- 🇺🇸
As0006 125, Birmingham, Alabama, United States
🇺🇸As0006 120, Scottsdale, Arizona, United States
🇺🇸As0006 115, Tucson, Arizona, United States
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Phase 3
Completed
- Conditions
- Ankylosing SpondylitisAxial Spondyloarthrithis
- First Posted Date
- 2015-07-22
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 736
- Registration Number
- NCT02505542
- Locations
- 🇺🇸
As0005 2313, Glendale, Arizona, United States
🇺🇸As0005 2316, Mesa, Arizona, United States
🇺🇸As0005 2314, Phoenix, Arizona, United States
Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors
Completed
- Conditions
- Brain Tumor Related Epilepsy (BTRE)
- First Posted Date
- 2014-10-27
- Last Posted Date
- 2020-06-01
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 93
- Registration Number
- NCT02276053
- Locations
- 🇫🇷
337, Lille, France
🇫🇷334, Lyon Cedex, France
🇫🇷335, Paris Cedex 13, France
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
Phase 1
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2014-09-03
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 57
- Registration Number
- NCT02230904
- Locations
- 🇩🇪
104, Alzenau, Germany
🇩🇪106, Aschaffenburg, Germany
🇩🇪105, Berlin, Germany
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2013-05-15
- Last Posted Date
- 2014-10-20
- Lead Sponsor
- UCB BIOSCIENCES GmbH
- Target Recruit Count
- 26
- Registration Number
- NCT01854216
- Locations
- 🇩🇪
1, Neuss, Germany
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found